The hytrin community assessment trial study: A one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia
- 1 February 1996
- journal article
- clinical trial
- Published by Elsevier BV in Urology
- Vol. 47 (2), 159-168
- https://doi.org/10.1016/s0090-4295(99)80409-9
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Benign Prostatic Hyperplasia Specific Health Status Measures in Clinical Research: How Much Change in the American Urological Association Symptom Index and the Benign Prostatic Hyperplasia Impact Index is Perceptible to Patients?Journal of Urology, 1995
- A three month double‐blind study of doxazosin as treatment for benign prostatic bladder outlet obstructionBritish Journal of Urology, 1994
- Terazosin in the treatment of benign prostatic hyperplasia. Terazosin Benign Prostatic Hyperplasia Study GroupArchives of Family Medicine, 1993
- Doxazosin Treatment in Patients with Prostatic ObstructionScandinavian Journal of Urology and Nephrology, 1993
- Alfuzosin for treatment of benign prostatic hypertrophyThe Lancet, 1991
- The efficacy and safety of terazosin for the treatment of symptomatic BPHThe Prostate, 1991
- Medical outcomes research and benign prostatic hyperplasiaThe Prostate, 1990
- Contractile properties of human prostate adenomas and the development of infravesical obstructionThe Prostate, 1989
- Symptom status and quality of life following prostatectomyJAMA, 1988
- Watchful waiting vs immediate transurethral resection for symptomatic prostatism. The importance of patients' preferencesJAMA, 1988